| Nov 3 |
This Beaten-Down Stock Just Gave Investors More Good News: Is it a Buy?
|
| Nov 3 |
3 Potential Catalysts That Could Lift Pfizer Stock Before 2025
|
| Nov 3 |
Pfizer Is A Good Stock To Buy After The Earnings
|
| Nov 2 |
Insider trades: Notable buys and sells by significant shareholders, executives and directors
|
| Nov 1 |
Pharma Stock Roundup: MRK, PFE, ABBV, NVS, LLY's Q3 Earnings in Focus
|
| Nov 1 |
3 Reasons Relying on Social Security Alone Could be a Risk. And 3 Stocks to Invest in Today.
|
| Nov 1 |
Cancer-Focused ESSA Pharma Ends Prostate Cancer Trial Due to Insufficient Efficacy From Combination Therapy
|
| Nov 1 |
Eli Lilly's Zepbound sales, Pfizer wants in on weight loss drugs, AbbVie's big deal: Pharma news round up
|
| Oct 31 |
Is Pfizer (NYSE:PFE) a High-Yielding Dividend Stock Worth Buying?
|
| Oct 31 |
Pfizer: Overstated Pessimism Makes Little Sense
|
